Q1 EPS Estimates for Abacus Life Raised by Northland Capmk

Abacus Life, Inc. (NASDAQ:ABL) – Equities research analysts at Northland Capmk boosted their Q1 2025 earnings estimates for shares of Abacus Life in a report issued on Friday, March 28th. Northland Capmk analyst M. Grondahl now anticipates that the company will earn $0.18 per share for the quarter, up from their previous estimate of $0.15. The consensus estimate for Abacus Life’s current full-year earnings is $0.62 per share. Northland Capmk also issued estimates for Abacus Life’s Q2 2025 earnings at $0.20 EPS, Q3 2025 earnings at $0.23 EPS, Q4 2025 earnings at $0.27 EPS and FY2025 earnings at $0.88 EPS.

Separately, B. Riley cut their target price on Abacus Life from $17.00 to $15.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $14.30.

Abacus Life Stock Up 6.6 %

Shares of ABL opened at $7.62 on Monday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.65. The business has a fifty day moving average of $7.62 and a 200 day moving average of $8.27. The company has a market cap of $736.43 million, a PE ratio of -42.33 and a beta of 0.14. Abacus Life has a 52-week low of $6.75 and a 52-week high of $12.50.

Abacus Life (NASDAQ:ABL) last posted its earnings results on Thursday, March 27th. The company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.03. The firm had revenue of $33.21 million during the quarter, compared to the consensus estimate of $28.76 million. Abacus Life had a positive return on equity of 12.88% and a negative net margin of 11.65%.

Institutional Trading of Abacus Life

Several institutional investors have recently bought and sold shares of ABL. Zimmer Partners LP lifted its position in shares of Abacus Life by 2.7% in the fourth quarter. Zimmer Partners LP now owns 617,910 shares of the company’s stock valued at $4,838,000 after acquiring an additional 16,457 shares in the last quarter. Squarepoint Ops LLC acquired a new position in Abacus Life in the 4th quarter valued at $113,000. Two Sigma Investments LP purchased a new position in Abacus Life in the 4th quarter valued at $617,000. Seven Grand Managers LLC boosted its stake in Abacus Life by 306.0% during the 4th quarter. Seven Grand Managers LLC now owns 507,485 shares of the company’s stock worth $3,974,000 after purchasing an additional 382,485 shares during the last quarter. Finally, Point72 Asset Management L.P. grew its holdings in shares of Abacus Life by 2.5% during the fourth quarter. Point72 Asset Management L.P. now owns 323,432 shares of the company’s stock worth $2,532,000 after buying an additional 7,838 shares in the last quarter.

Abacus Life Company Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.